Early primary tumor response in metastatic RCC patients treated with immune checkpoint inhibitors-based combinations

MLA

Chiara Ciccarese, et al. “Early Primary Tumor Response in Metastatic RCC Patients Treated with Immune Checkpoint Inhibitors-Based Combinations.” Journal of Clinical Oncology, vol. 40, Feb. 2022, p. 349. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f1e0fd58a26be8a242d61433253dc946&authtype=sso&custid=ns315887.

APA

Chiara Ciccarese, Davide Bimbatti, Francesco Atzori, Adele Bonato, Sarah Scagliarini, Ilaria Pellegrini, Sergio Bracarda, Ugo De Giorgi, Cristina Masini, Matteo Santoni, Francesco Massari, Sebastiano Buti, Alessandra Damassi, Ilaria Zampiva, Alessandro Strusi, Ileana Sparagna, Sara Elena Rebuzzi, Giampaolo Tortora, & Roberto Iacovelli. (2022). Early primary tumor response in metastatic RCC patients treated with immune checkpoint inhibitors-based combinations. Journal of Clinical Oncology, 40, 349.

Chicago

Chiara Ciccarese, Davide Bimbatti, Francesco Atzori, Adele Bonato, Sarah Scagliarini, Ilaria Pellegrini, Sergio Bracarda, et al. 2022. “Early Primary Tumor Response in Metastatic RCC Patients Treated with Immune Checkpoint Inhibitors-Based Combinations.” Journal of Clinical Oncology 40 (February): 349. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f1e0fd58a26be8a242d61433253dc946&authtype=sso&custid=ns315887.